CGP 550 Plus and CGP 270 Plus Cancer Testing
How the panels differ and how to read a comprehensive genomic profile
Knowledge library
Ideas, guides and answers from Oncquest Laboratories
Explore practical articles, visual explainers and clear answers from our latest published knowledge.
Trending Articles
Hereditary Breast and Ovarian Cancer Syndrome: Genes, Risk and Testing
Understand HBOC, BRCA1/2 and other genes, inheritance, counselling, test choices and why a negative BRCA result may not exclude hereditary risk.
How to Read an NGS Cancer Report
Variants, biomarkers, evidence tiers and the questions to take to your oncologist
MSI Testing in Cancer: MSI-High, PCR, IHC and Results
Understand MSI-high, MSI-low, MSS and dMMR, how PCR, IHC and NGS testing work, and how cancer biomarker reports are interpreted.
Trending Visual Explainers
Trending FAQs
Does CGP find every cancer mutation
No. It tests validated genes regions and alteration types. Tissue quality tumor fraction coverage and tumor heterogeneity also affect detection.
Read the full answerIs CGP 550 Plus always better than CGP 270 Plus
Yes. The broader panel can answer additional questions, but the best choice depends on the tumor type clinical need previous results tissue and current guidance.
Read the full answerDoes CGP 270 Plus report TMB
TMB is not listed as a formal CGP 270 Plus output in the current catalog or attached sample report. It is explicitly listed for CGP 550 Plus. Confirm the current assay scope when ordering.[1][2][4][5]
Read the full answerEditorial review
Written and reviewed by our experts
Behind the answers
11/11
articles in this library credit both their writers and reviewers.
3 contributors 4 topics
Team Oncquest
Oncquest Laboratories Ltd is known for its excellence in Clinical Diagnostics.
11 written
4 topics
View profile
Reviewer
Dr. Jasmine Kaur
Dr. Jasmine Kaur is a Consultant in R&D in the Molecular Biology and Genomics Department at Oncquest Laboratories.
10 reviewed
4 topics
View profile
Reviewer
Dr. Monica Verma
Dr. Monica Verma is Head of Surgical Pathology at Oncquest Laboratories.
1 reviewed
1 topic
View profile
Connected reading
Explore topic collections
Breast Cancer Genomic Testing & Diagnostics
3 articles
Cancer Biomarkers & Immunotherapy Testing
3 articles
Hereditary Cancer Risk & Genetic Testing
2 articles
Publication log
Recently published
published
[ Comprehensive Genomic P… ]
How to Read an NGS Cancer Report
published
[ Comprehensive Genomic P… ]
CGP 550 Plus and CGP 270 Plus Cancer Testing
published
[ Breast Cancer Genomic T… ]
MammaPrint and BluePrint Breast Cancer Testing
published
[ Comprehensive Genomic P… ]
Variant Allele Frequency in Cancer NGS Reports
published
[ Cancer Biomarkers & Imm… ]
Gene Fusions in Cancer